Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Assessing arterial stiffness and heart disease risk using a novel technology

Official title: Cardio Alpha - Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment

Run by HJN Sverige AB/Neko Health · NCT06984211 · Data updated 2026-11-12

This study is testing a new, no-touch technology to measure how stiff your arteries are and see if it can help figure out your risk for heart disease.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment8000 (estimated)
SponsorHJN Sverige AB/Neko Health
Industry-sponsored
Locations3 sites (Stockholm and 2 other locations)
StatusRecruiting
StartedFebruary 1, 2023
Main results expectedFebruary 1, 2026
Study endsFebruary 1, 2026
Registry record updatedMay 22, 2025
Trial IDNCT06984211 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adult patients within the regular healthcare flow at the investigational sites who can provide informed consent.

Probably not a fit

Patients with cognitive impairments or severe terminal diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical investigation evaluates a new contactless technology for measuring arterial stiffness and its potential in assessing cardiovascular disease risk. The study focuses on a primary care cohort, utilizing a laser-radar-based vibrometer to gather data on arterial stiffness and cardiovascular health. Participants will undergo various assessments, including blood pressure measurements and ECG, with additional investigations for those at higher risk of cardiovascular issues. The aim is to improve the precision of cardiovascular disease risk assessment through a multi-modal approach.

Why it matters

Potential benefit: If successful, this study could lead to more accurate assessments of cardiovascular disease risk, potentially improving patient outcomes.

How similar studies have gone: While the approach is innovative, similar studies have shown promise in assessing cardiovascular risk using non-invasive methods.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation.
* Patients with signed informed consent

Exclusion criteria:

* Cognitive impairment
* Patients unable to understand the oral and written study information in Swedish or English
* Other severe disorder or terminal disease, e.g. infection/sepsis, severe COPD or metastatic cancers.
* Patients unable to provide an informed consent

Where it's running

  • Atrium Health Care Centre
    Stockholm, Sweden
    Recruiting
  • Neko Health Centre, Regeringsgatan
    Stockholm, Sweden
    Recruiting
  • Neko Health Centre, Sibyllegatan
    Stockholm, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.